Patents by Inventor Curt R. Freed

Curt R. Freed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISEASE
    Publication number: 20190038589
    Abstract: The present invention provides a method and composition for treating a neurodegenerative disease. In particular, the present invention provides a method and composition to increase DJ-1 gene expression or DJ-1 protein activity to treat a neurodegenerative disease.
    Type: Application
    Filed: October 10, 2018
    Publication date: February 7, 2019
    Inventors: CURT R. FREED, WENBO ZHOU
  • Composition and method for treating neurodegenerative disease
    Patent number: 10130604
    Abstract: The present invention provides a method and composition for treating a neurodegenerative disease. In particular, the present invention provides a method and composition to increase DJ-1 gene expression or DJ-1 protein activity to treat a neurodegenerative disease.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: November 20, 2018
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Curt R. Freed, Wenbo Zhou
  • COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISEASE
    Publication number: 20170224646
    Abstract: The present invention provides a method and composition for treating a neurodegenerative disease. In particular, the present invention provides a method and composition to increase DJ-1 gene expression or DJ-1 protein activity to treat a neurodegenerative disease.
    Type: Application
    Filed: September 22, 2016
    Publication date: August 10, 2017
    Inventors: Curt R. Freed, Wenbo Zhou
  • Composition and method for treating neurodegenerative disease
    Patent number: 9480673
    Abstract: The present invention provides a method and composition for treating a neurodegenerative disease. In particular, the present invention provides a method and composition to increase DJ-1 gene expression or DJ-1 protein activity to treat a neurodegenerative disease.
    Type: Grant
    Filed: March 28, 2013
    Date of Patent: November 1, 2016
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Curt R. Freed, Wenbo Zhou
  • COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISEASE
    Publication number: 20150087703
    Abstract: The present invention provides a method and composition for treating a neurodegenerative disease. In particular, the present invention provides a method and composition to increase DJ-1 gene expression or DJ-1 protein activity to treat a neurodegenerative disease.
    Type: Application
    Filed: March 28, 2013
    Publication date: March 26, 2015
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Curt R. Freed, Wenbo Zhou
  • Dopamine neurons from human embryonic stem cells
    Publication number: 20040147020
    Abstract: The present invention relates to methods and compositions for differentiating human embryonic stem cells into dopamine producing neurons. The methods and compositions of the present invention are suitable for use in the treatment of neurological disorders.
    Type: Application
    Filed: October 30, 2003
    Publication date: July 29, 2004
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Curt R. Freed, Kimberley A. Buytaert-Hoefen
  • Method of treating huntington's disease using HNT neurons
    Patent number: 6254865
    Abstract: The present invention relates to methods and compositions for transplantation of neurons. The methods and compositions of the present invention provide a renewable supply of safe and effective therapeutic transplantable tissue. In particular, the present invention provides methods and compositions for the transplantation of terminally differentiated neurons derived from cell lines for the treatment of Huntington's disease and other neurological disorders.
    Type: Grant
    Filed: June 17, 1998
    Date of Patent: July 3, 2001
    Assignee: University Technology Corporation
    Inventors: Curt R. Freed, Farida G. Kaddis
  • Immortalized human fetal neuronal cell line
    Patent number: 6232119
    Abstract: An immortalized line of human fetal brain cells capable of synthesizing dopamine has been developed. No tumor formation or rejection at 30 days post-transplantation has been detected. The cells are useful for transplantation therapy of a neurological deficit characterized by dopamine deficiency in the local region of the brain.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: May 15, 2001
    Assignee: University Technology Corporation
    Inventors: Kedar N. Prasad, Curt R. Freed